SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group

To SMILE or Not: Supportive Care Matters

(2012) Alexandre Chan et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

(2011) Motoko Yamaguchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

(2010) A. Jaccard et al.   BLOOD

Metabolic Activity Measured by F-18 FDG PET in Natural Killer-Cell Lymphoma Compared to Aggressive B- and T-Cell Lymphomas

(2010) Winnie K. S. Chan et al.   CLINICAL NUCLEAR MEDICINE

Diagnosis and management of natural killer-cell malignancies

(2010) Fumihiro Ishida et al.   Expert Review of Hematology

High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies

(2009) Y-L Kwong   BONE MARROW TRANSPLANTATION

Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211

(2009) Motoko Yamaguchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study

(2009) Seok Jin Kim et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia

(2008) Motoko Yamaguchi et al.   CANCER SCIENCE